Clinical trial
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy…
NCT00464789 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00464789 |
|---|---|
| Title | Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women |
| Official title | An Open-Label, Single-Dose, Randomized, 3-Period, Crossover, Bioequivalence Study Between Bazedoxifene/Conjugated Estrogens (Premarin Current Process) And Bazedoxifene/Conjugated Estrogens (Premarin New Process) In Healthy Postmenopausal Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug |
| Interventions | Bazedoxifene/Conjugated Estrogens 20 mg/0.625 mg tablet |
| Start date | Mar 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Apr 24, 2007 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: